# Safety Study of Anti-Asthma Agent BMEC-1217B

> **NCT00425971** · PHASE1 · UNKNOWN · sponsor: **Medigreen Biotechnology Corp.** · enrollment: 32 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** BMEC-1217B

## Key facts

- **NCT ID:** NCT00425971
- **Lead sponsor:** Medigreen Biotechnology Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2008-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00425971

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00425971, "Safety Study of Anti-Asthma Agent BMEC-1217B". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00425971. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*